SRDX
Price
$37.46
Change
-$0.18 (-0.48%)
Updated
Aug 15 closing price
Capitalization
535.59M
80 days until earnings call
TFX
Price
$120.68
Change
-$0.82 (-0.67%)
Updated
Aug 15 closing price
Capitalization
5.33B
67 days until earnings call
Interact to see
Advertisement

SRDX vs TFX

Header iconSRDX vs TFX Comparison
Open Charts SRDX vs TFXBanner chart's image
Surmodics
Price$37.46
Change-$0.18 (-0.48%)
Volume$408.96K
Capitalization535.59M
Teleflex
Price$120.68
Change-$0.82 (-0.67%)
Volume$322.16K
Capitalization5.33B
SRDX vs TFX Comparison Chart in %
Loading...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SRDX vs. TFX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SRDX is a Hold and TFX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (SRDX: $37.46 vs. TFX: $120.68)
Brand notoriety: SRDX and TFX are both not notable
SRDX represents the Medical/Nursing Services, while TFX is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SRDX: 255% vs. TFX: 57%
Market capitalization -- SRDX: $535.59M vs. TFX: $5.33B
SRDX [@Medical/Nursing Services] is valued at $535.59M. TFX’s [@Pharmaceuticals: Other] market capitalization is $5.33B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $229.31B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $172.16B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.55B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SRDX’s FA Score shows that 0 FA rating(s) are green whileTFX’s FA Score has 1 green FA rating(s).

  • SRDX’s FA Score: 0 green, 5 red.
  • TFX’s FA Score: 1 green, 4 red.
According to our system of comparison, TFX is a better buy in the long-term than SRDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SRDX’s TA Score shows that 3 TA indicator(s) are bullish while TFX’s TA Score has 5 bullish TA indicator(s).

  • SRDX’s TA Score: 3 bullish, 4 bearish.
  • TFX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TFX is a better buy in the short-term than SRDX.

Price Growth

SRDX (@Medical/Nursing Services) experienced а +5.79% price change this week, while TFX (@Pharmaceuticals: Other) price change was +2.20% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +7.68%. For the same industry, the average monthly price growth was +8.00%, and the average quarterly price growth was +7.22%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.19%. For the same industry, the average monthly price growth was -0.65%, and the average quarterly price growth was +3.82%.

Reported Earning Dates

SRDX is expected to report earnings on Nov 05, 2025.

TFX is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Medical/Nursing Services (+7.68% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+0.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TFX($5.33B) has a higher market cap than SRDX($536M). SRDX has higher P/E ratio than TFX: SRDX (43.13) vs TFX (28.13). SRDX YTD gains are higher at: -5.404 vs. TFX (-31.653). SRDX has less debt than TFX: SRDX (32.8M) vs TFX (2B).
SRDXTFXSRDX / TFX
Capitalization536M5.33B10%
EBITDA-2.59MN/A-
Gain YTD-5.404-31.65317%
P/E Ratio43.1328.13153%
Revenue122MN/A-
Total Cash31.1MN/A-
Total Debt32.8M2B2%
FUNDAMENTALS RATINGS
SRDX vs TFX: Fundamental Ratings
SRDX
TFX
OUTLOOK RATING
1..100
737
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9586
PRICE GROWTH RATING
1..100
4263
P/E GROWTH RATING
1..100
9488
SEASONALITY SCORE
1..100
34n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TFX's Valuation (29) in the Medical Specialties industry is somewhat better than the same rating for SRDX (93). This means that TFX’s stock grew somewhat faster than SRDX’s over the last 12 months.

TFX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as SRDX (100). This means that TFX’s stock grew similarly to SRDX’s over the last 12 months.

TFX's SMR Rating (86) in the Medical Specialties industry is in the same range as SRDX (95). This means that TFX’s stock grew similarly to SRDX’s over the last 12 months.

SRDX's Price Growth Rating (42) in the Medical Specialties industry is in the same range as TFX (63). This means that SRDX’s stock grew similarly to TFX’s over the last 12 months.

TFX's P/E Growth Rating (88) in the Medical Specialties industry is in the same range as SRDX (94). This means that TFX’s stock grew similarly to SRDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SRDXTFX
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
73%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
52%
MACD
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
55%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
52%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
51%
Advances
ODDS (%)
Bullish Trend 7 days ago
67%
Bullish Trend 5 days ago
54%
Declines
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
65%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
66%
Bearish Trend 3 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LHCOX19.430.12
+0.62%
Lord Abbett Health Care F3
PFRSX28.130.16
+0.57%
Principal Real Estate Securities Fd R6
GCGIX37.09-0.02
-0.05%
Goldman Sachs Large Cap Gr Insghts Instl
MGOCX33.90-0.08
-0.24%
NYLI WMC Enduring Capital Class C
HDSIX22.91-0.10
-0.43%
Hodges Small Cap Grwoth Institutional

SRDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRDX has been loosely correlated with PXMBF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SRDX jumps, then PXMBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRDX
1D Price
Change %
SRDX100%
-0.48%
PXMBF - SRDX
41%
Loosely correlated
N/A
BDX - SRDX
32%
Poorly correlated
+0.48%
BLCO - SRDX
30%
Poorly correlated
+3.34%
TFX - SRDX
29%
Poorly correlated
-0.40%
UFPT - SRDX
28%
Poorly correlated
-1.99%
More

TFX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TFX has been loosely correlated with A. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TFX jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TFX
1D Price
Change %
TFX100%
-0.40%
A - TFX
50%
Loosely correlated
+0.28%
BDX - TFX
47%
Loosely correlated
+0.48%
RVTY - TFX
45%
Loosely correlated
+1.49%
TNDM - TFX
45%
Loosely correlated
+1.50%
SNN - TFX
44%
Loosely correlated
-1.15%
More